BiotechTube
Home/VahatiCor/Janie Mandrusov
JM

Janie Mandrusov

VP, Clinical Affairs

VahatiCor

Therapeutic Areas

Cardiovascular

VahatiCor Pipeline

DrugIndicationPhase
A-FLUX Reducer SystemCoronary Microvascular Dysfunction (CMD)Early Feasibility

Leadership Team at VahatiCor

MB
Marwan Berrada
Founder and Chairman
KV
Kevin Van Bladel
Chief Technology Officer
MM
Michael Mandel
Head of Corporate Development
AM
Angela Mallery
VP of Regulatory and Quality Affairs
View full VahatiCor profile